Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Technology Gap Separates OTC Drug Firms From Self-Care Sales Growth

Executive Summary

OTC drug firms should offer more digital tools that guide consumers in product purchases, says a health care marketing executive. The American Pharmacists Association suggests firms also strengthen outreach with pharmacists.


Related Content

Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
Independent Pharmacies Stock Growth Opportunities In Health, Wellness And Beauty Aisles
CVS Standards: Another Step In Supplement Industry Transparency Evolution
Reckitt Reaps ROI Reward In Geo-Targeted Symptoms App Promoting Mucinex, Delsym
'Evolving' With Health Care, CHPA Considers Device, Supplement Sectors
‘Double Check’ Acetaminophen Message Reaches Walmart Pharmacies
Can You Reach Us Now? Mobile Connections A Must For OTC Sales Growth In Digital World
Climb In Consumer Self-Care, Slide In Rx Margin Boost Front-Of-Store Pharmacy Sales
P&G Tech Toothbrush May Foretell OTC Switch Future
FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts